GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,708.60p
   
  • Change Today:
      3.40p
  • 52 Week High: 1,713.00
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 7,547,306
  • Market Cap: £70,819m
  • RiskGrade: 129

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart (28-03-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 2.5% 0.0%
Div Cover 3.7 2.6
Op Mrgn 22.2% 27.5%
ROCE 67.1%  
Latest F'cast
P/E 11.0 10.7
PEG 1.0 6.9
Pr/Revenue 2.3 2.2
Pr/Book 5.5  
Latest F'cast
Revenue 3.4% 4.2%
PBT 7.7% 43.4%
EPS 11.0% 1.6%
DPS -4.5% 45.1%

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 42.00p 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31,610.91 8,698.11 157.55p 10.8 6.8 +2% 60.93p 0.0%
31-Dec-25 33,528.80 9,686.24 176.36p 9.7 0.8 +12% 65.44p 0.0%
31-Dec-26 35,219.41 10,689.29 192.66p 8.9 1.0 +9% 71.16p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

GSK Company Announcements

Director/PDMR Shareholding 26-Mar-2024 15:30 RNS
Notice of AGM 25-Mar-2024 13:00 RNS
Transfer of Treasury Shares 22-Mar-2024 16:20 RNS

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
20-Mar-24 Buy Vishal Sikka 1,638.72p 378 £6,194.36
20-Mar-24 Buy Elizabeth (Liz) McKee Anderson 1,638.72p 438 £7,177.59
20-Mar-24 Buy Jesse Goodman 1,638.72p 438 £7,177.57

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,708.60p
Change Today 3.40p
% Change 0.20 %
52 Week High 1,713.00
52 Week Low 1,316.00
Volume 7,547,306
Shares Issued 4,144.88m
Market Cap £70,819m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.07% below the market average83.07% below the market average83.07% below the market average83.07% below the market average83.07% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Price Trend
50.74% above the market average50.74% above the market average50.74% above the market average50.74% above the market average50.74% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
31.40% above the market average31.40% above the market average31.40% above the market average31.40% above the market average31.40% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

What The Brokers Say

Strong Buy 7
Buy 6
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 28-Mar-2024

Time Volume / Share Price
17:14 750,000 @ 1,709.81p
17:04 13,917 @ 1,706.01p
17:04 13,076 @ 1,706.01p
17:04 549 @ 1,706.01p
17:03 172,458 @ 1,706.01p

GSK Key Personnel

CEO Emma Walmsley

Top of Page